AIP vs CEVA

For growth investors, Arteris, Inc.

(AIP) is the stronger pick with 22. 3% revenue growth year-over-year, versus 9. 8% for CEVA, Inc. (CEVA). Analysts rate Arteris, Inc. (AIP) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Arteris, Inc.

(AIP) delivered a total return of +64. 7%, compared to -35. 4% for CEVA, Inc. (CEVA). Over 10 years, the gap is even starker: AIP returned +64. 7% versus CEVA's +27. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CEVA, Inc.

(CEVA) is the lower-risk stock at 2. 76β versus Arteris, Inc. 's 3. 01β — meaning AIP is approximately 9% more volatile than CEVA relative to the S&P 500.

By revenue growth (latest reported year), Arteris, Inc.

(AIP) is pulling ahead at 22. 3% versus 9. 8% for CEVA, Inc. (CEVA). On earnings-per-share growth, the picture is similar: CEVA, Inc. grew EPS 27. 5% year-over-year, compared to 4. 7% for Arteris, Inc.. Over a 3-year CAGR, AIP leads at 11. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CEVA, Inc.

(CEVA) is the more profitable company, earning -8. 2% net margin versus -49. 2% for Arteris, Inc. — meaning it keeps -8. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CEVA leads at -7. 1% versus -47. 0% for AIP. At the gross margin level — before operating expenses — AIP leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for CEVA: -13.

0% to $29. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Arteris, Inc.

(AIP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. CEVA, Inc. (CEVA) carries a higher beta of 2. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AIP: +64. 7%, CEVA: +27. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AIP is a small-cap high-growth stock; CEVA is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.